Study reveals why a rare mutation behind Dravet syndrome is so deadly

Findings point to the importance of an understudied piece of DNA called an intron

3:30 PM

Author | Kelly Malcom

MRNA splicing transcription on a blue background
More rare variants of the SCN1B gene can cause a particularly severe form of Dravet syndrome, new research finds.

Dravet syndrome is a rare developmental disease that causes epileptic seizures along with movement and balance disorders, intellectual disability, cognitive delay and other issues in children. Devastatingly, Dravet syndrome increases the risk of sudden unexplained death in epilepsy (SUDEP).  

 

A mutation in the SCN1A gene accounts for around 90 percent of cases. Other more rare variants of the SCN1B gene can cause a particularly severe form of Dravet syndrome. 

 

“For Dravet syndrome, there’s usually a 20 percent rate of SUDEP, but for patients with the SCN1B c.449-2A>G variant, it was essentially 100 percent,” said Lori Isom, Ph.D., Professor of Pharmacology, Neurology, and Molecular and Integrative Physiology.  

 

Her team, including Shreeya Bakshi, Ph.D., a postdoctoral fellow, wanted to understand what made this variant so lethal. 

 

The variant in question, SCN1B c.449-2A>G, stood out because it affected an intron, said Bakshi. In the DNA to RNA to protein translation process, introns are typically cut out of RNA. Previously, scientists regarded introns as junk DNA. But the team discovered their proper removal had enormous consequences. 

 

“Basically, what this patient variant does is affect how that intron is removed, and that's what ends up resulting in this very severe form of epilepsy,” said Bakshi. Essentially, because the intron isn’t removed, the gene is spliced incorrectly, and no functional protein is produced. 

 

Severe type of Dravet syndrome 

Isom’s lab has demonstrated previously that in mouse models bred to lack the SCN1B gene, neurons and heart muscle cells cannot control their excitability, resulting in severe epilepsy, cardiac arrhythmia, and death. This was the first time they saw this severe type of Dravet syndrome in a patient.  

 

The finding hints at a way of fixing the problem: removing the intron.  

 

“If you have the intron included in there, you're going to have less protein. If you could somehow increase intron removal for this variant, you'd increase the amount of functional protein. But right now, there's not a lot of research that focuses on introns that are retained,” said Bakshi.  

 

Bakshi is interested in understanding how intron retention is regulated not just in SCN1B but all genes. 

 

Potential gene therapy 

Last year, Isom’s team published a paper detailing a potential gene therapy for Dravet syndrome that they are testing along with colleagues at Children's Hospital of Philadelphia, which replaces the mutated gene in patients with an SCN1B variant with the wildtype gene so that cells can create the correct protein. 

 

Bakshi and Isom are working with Michelle Hastings, Ph.D. on another, potentially safer approach using antisense oligonucleotides, a type of RNA therapy that can fix how a gene is being expressed.  

 

“Studying diseases at the basic science level is so important because it helps us understand what the problem is and ways we can potentially address it,” said Bakshi. “Our work is in early stages, but we’re hopeful.” 

 

Paper cited: “SCN1B intron 3 retention results in a nonsense-mediated decay sensitive mRNA linked to developmental and epileptic encephalopathy,” PNAS, DOI: 10.1073/pnas.2531330123 

 

Additional authors: Amanda M. Catalfio, Chunling Chen, Yukun Yuan, Luis F. Lopez-Santiago, Chloe Moore, Daniel S. Seagull, Sahana Macedo, Aazif Hussein, Isha Verma, Kyle Stokes, Joe Minton, Louis T. Dang, Christelle M El Achkar, Annapurna Poduri, Jack M. Parent

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week. 

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows. 

 

 


More Articles About:

children with dravet syndrome Dravet syndrome Genetics Basic Science and Laboratory Research
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Dr. Lori Isom

Lori L Isom, PhD

Professor

Related

drawing of a pink brain on a dark pink background
Health Lab

Investigational New Therapy Prevents Onset of Dravet Syndrome Symptoms in Mice

Development is first step to helping children with the rare epilepsy syndrome.
doctors sitting together smiling at camera in office with computer in background
Health Lab

Finding answers for Dravet syndrome, a deadly form of epilepsy

Michigan Medicine researchers talk about changing the disease course of Dravet syndrome and families caring for the condition.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
1906 psychopathic hospital
News Release

Exploring the mind’s mysteries: 130 years of mental health care & innovation at U-M

When it opened in 1906 on Catherine Street near the University of Michigan’s main hospitals, the stately brick State Psychopathic Hospital meant something new in the world of mental health.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.
Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .
Father comforts sick child
News Release

15 years of data will help uncover how flu spreads—and how to reduce its impact

$14.2-million NIH award to University of Michigan funds research to untangle intricacies of person-to-person flu transmission—and reduce illness, deaths, economic losses